PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells

Nan Wu(Propulsion Science and Technology (United States)), Osamu Miura(Hoag Orthopedic Institute)

International Journal of Oncology

December 6, 2012

10.3892/ijo.2012.1729

Cited by 8

Related Papers

A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence

|Journal of Clinical Investigation|2017|48

Inhibition of the PI3K/Akt/GSK3 Pathway Downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD Downregulates DNA Damage-Induced Chk1 Activation as Well as G2/M Arrest and Prominently Enhances Induction of Apoptosis

|PLoS ONE|2013|42

Proliferation and Survival Signaling from Both Jak2-V617F and Lyn Involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 Cell Line Newly Established from Acute Myeloid Leukemia Transformed from Polycythemia Vera

|PLoS ONE|2014|25

DNA Damage Stress and Inhibition of Jak2-V617F Cause Its Degradation and Synergistically Induce Apoptosis through Activation of GSK3β

|PLoS ONE|2011|15

Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report

|Oncology Letters|2017|14